474 related articles for article (PubMed ID: 37108382)
1. Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson.
Tassone A; Meringolo M; Ponterio G; Bonsi P; Schirinzi T; Martella G
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108382
[TBL] [Abstract][Full Text] [Related]
2. Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases.
Gubellini P; Picconi B; Di Filippo M; Calabresi P
Biochim Biophys Acta; 2010 Jan; 1802(1):151-61. PubMed ID: 19683569
[TBL] [Abstract][Full Text] [Related]
3. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
Hroudová J; Singh N; Fišar Z
Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
[TBL] [Abstract][Full Text] [Related]
5. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial diseases of the brain.
Chaturvedi RK; Flint Beal M
Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
[TBL] [Abstract][Full Text] [Related]
7. Regional susceptibilities to mitochondrial dysfunctions in the CNS.
Pinto M; Pickrell AM; Moraes CT
Biol Chem; 2012 Apr; 393(4):275-81. PubMed ID: 23029655
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
9. The multi-faceted role of mitochondria in the pathology of Parkinson's disease.
Trinh D; Israwi AR; Arathoon LR; Gleave JA; Nash JE
J Neurochem; 2021 Mar; 156(6):715-752. PubMed ID: 33616931
[TBL] [Abstract][Full Text] [Related]
10. Mitophagy in neurodegenerative diseases.
Rodolfo C; Campello S; Cecconi F
Neurochem Int; 2018 Jul; 117():156-166. PubMed ID: 28797885
[TBL] [Abstract][Full Text] [Related]
11. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
[TBL] [Abstract][Full Text] [Related]
12. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal MF
Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.
Chaturvedi RK; Beal MF
Mol Cell Neurosci; 2013 Jul; 55():101-14. PubMed ID: 23220289
[TBL] [Abstract][Full Text] [Related]
14. Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
Hague SM; Klaffke S; Bandmann O
J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1058-63. PubMed ID: 16024878
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
[TBL] [Abstract][Full Text] [Related]
17. Calcium-Handling Defects and Neurodegenerative Disease.
Schrank S; Barrington N; Stutzmann GE
Cold Spring Harb Perspect Biol; 2020 Jul; 12(7):. PubMed ID: 31427373
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.
Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM
Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in Huntington's and Parkinson's Disease.
O'Keeffe GC; Michell AW; Barker RA
Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264
[TBL] [Abstract][Full Text] [Related]
20. Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.
Jamwal S; Kumar P
Curr Neuropharmacol; 2019; 17(2):165-175. PubMed ID: 29512464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
